Why the study?
Left ventricular hypertrophy is a critical predictor of cardiovascular disease, creating a need for efficient, accurate, and scalable medical image analysis for automated diagnosis.
Does a novel DCNN architecture improve the accuracy of automated LVH diagnosis from echocardiography images compared to standard benchmark models?
Does a novel DCNN architecture improve the accuracy of automated LVH diagnosis from echocardiography images compared to standard benchmark models?
A novel DCNN architecture demonstrates high accuracy (98% on testing) for the automated detection of left ventricular hypertrophy from echocardiography images, outperforming standard benchmark models.
Left Ventricular Hypertrophy (LVH) is a critical predictor of cardiovascular disease, making it essential to incorporate it as a fundamental parameter in both diagnostic screening and clinical management. Addressing the need for efficient, accurate, and scalable medical image analysis, we introduce a state-of-the-art preprocessing pipeline coupled with a novel Deep Convolutional Neural Network (DCNN) architecture. This paper details our choice of the HMC-QU dataset, selected for its robustness and its proven efficacy in enhancing model generalization. We also describe innovative preprocessing techniques aimed at improving the quality of input data, thereby boosting the model's feature extraction capabilities. Our multi-disciplinary approach includes deploying a DCNN for automated LVH diagnosis using echocardiography A4C and A2C images. We evaluated the model using architectures based on VGG16, ResNet50, and InceptionV3, where our proposed DCNN exhibited enhanced performance. In our study, 93 out of 162 A4C recordings and 68 out of 130 A2C recordings confirmed the presence of LVH. The novel DCNN model achieved an impressive 99.8% accuracy on the training set and 98.0% on the test set. Comparatively, ResNet50 and InceptionV3 models showed lower accuracy and higher loss values both in training and testing phases. Our results underscore the potential of our DCNN architecture in enhancing the precision of MRI echocardiograms in diagnosing LVH, thereby providing critical support in the screening and treatment of cardiovascular conditions. The high accuracy and minimal losses observed with the novel DCNN model indicate its utility in clinical settings, making it a valuable tool for improving patient outcomes in cardiovascular care. • Novel DCNN detects LVH in echocardiography, outperforming state-of-the-art models VGG16, ResNet50, and InceptionV3 models. • Achieved 99.8% training and 98% testing accuracy, proving reliability in medical diagnostics. • Advanced preprocessing enhances input images via noise reduction, normalization, and augmentation. • Evaluated with metrics like sensitivity, precision, and AUC-ROC, surpassing benchmark models. • User-friendly interface enables clinical LVH detection, reducing variability and improving efficiency.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: